As a DNMT inhibitor, RG108 can effectively inhibit DNA methylation and reactivate the GSDME gene, which can be cleaved by Caspase‐3 induced by CDDP, then triggers the pyroptosis in tumor cells and produces immunotherapeutic effects. The gene discussed is GSDME; the disease is neoplasm.